Sijibio Obtains Cell Processing Facility Approval from MFDS... "Accelerating Stem Cell Therapy Development"
[Asia Economy Reporter Lee Gwan-joo] CJ Bio announced on the 30th that it has obtained approval from the Ministry of Food and Drug Safety for an advanced regenerative medical cell processing facility.
A cell processing facility is an institution specializing in the processing of human cells. Advanced regenerative medical institutions conducting clinical research on advanced biopharmaceuticals such as cell therapy products must use only human cells supplied from cell processing facilities approved by the Ministry of Food and Drug Safety.
CJ Bio is currently developing stem cell therapy products using autologous adipose-derived stem cells. To this end, CJ Bio plans to supply high-quality stem cells collected and processed at its cell processing facility to domestic hospitals approved as advanced regenerative medical institutions and conduct various clinical studies.
Furthermore, through collaboration with advanced regenerative medical institutions in the future, CJ Bio plans to expand the indications of the stem cell therapy products currently under development and develop additional advanced biopharmaceuticals to broaden its regenerative medical solution portfolio.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
- Suspicious Starbucks Numbers?... 'Tank Day' Controversy Spreads from May 18 to Sewol Ferry and Park Geun-hye
- "Reporters Who First Revealed Jo Jinwoong's Juvenile Offense History Cleared of Juvenile Act Violation"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
CEO Yoo Hyun-seung said, “With this approval, CJ Bio can expand its research and development area to stem cell-based advanced biopharmaceuticals,” adding, “Based on our commercialization experience with scaffold and growth factor-based products, we will successfully develop stem cell therapy products and become a company that can help patients suffering from intractable diseases.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
